2019
High-flux hemodialysis versus glucarpidase for methotrexate-associated acute kidney injury: What’s best?
Kitchlu A, Shirali A. High-flux hemodialysis versus glucarpidase for methotrexate-associated acute kidney injury: What’s best? Journal Of Onco-Nephrology 2019, 3: 11-18. DOI: 10.1177/2399369319827305.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus Statements
2015
Nephrotoxicity of Chemotherapy Agents
Valika A, Shirali A. Nephrotoxicity of Chemotherapy Agents. 2015, 65-91. DOI: 10.1007/978-1-4939-2659-6_4.Peer-Reviewed Original ResearchChemotherapy agentsAnti-vascular endothelial growth factor agentsEndothelial growth factor agentsChemotherapy-induced nephrotoxicityIntrinsic renal injurySite-specific injuryAcute tubular necrosisGrowth factor agentsGlomerular endothelial damageAdverse drug effectsDistinct clinical syndromeFactor agentsCrystal nephropathyHemodynamic statusPatient characteristicsRenal injuryTubular necrosisEndothelial damageKidney functionClinical syndromeVascular injuryKidney microenvironmentMalignant diseaseGlomerular diseaseDrug effects